No Data
No Data
China Resources Pharmaceutical Logs 3% Lower Profit in H1
China Resources Pharmaceutical Group: To Strengthen Post-Investment Management, Compliance Monitoring via Digital Solutions >3320.HK
Chinares Pharma (03320) will distribute a mid-term dividend of HKD 0.083 per share on October 30th.
Chinare Pharmaceutical (03320) announced that it will distribute dividends on October 30, 2024 for the period ending June 3, 2024...
Chinares Pharma (03320.HK) achieved a net income of 5.54 billion yuan in the first half of the year, a year-on-year increase of 10.2%.
On August 29th, Guolonghui announced that chinare's pharma (03320.HK) recorded a total income of 12,859.76 million yuan in the first half of 2024, an increase of 4.7% from the total income of 12,281.84 million yuan in the same period last year. In the first half of 2024, the pharmaceutical, pharmaceutical distribution, and pharmaceutical retail business segments of the three main business units of the group accounted for 16.5%, 79.6%, and 3.9% of the total income respectively. During the reporting period, the group achieved a gross profit of 2,093.35 million yuan, a 5% increase from the gross profit of 1,976.06 million yuan in the first half of 2023.
Express News | China Resources Pharmaceutical - Interim Dividend of HK$0.0908 per Ordinary Share
Express News | China Resources Pharmaceutical Group H1 Gross Profit RMB 20,933.5 Million
No Data